Abstract | PURPOSE: METHODS: A total of 69 gastric cancer patients with PM and LNM who received neoadjuvant intraperitoneal and systemic chemotherapy ( NIPS) of intraperitoneal docetaxel (DXT) and cisplatin (CDDP); intravenous chemotherapy of DXT and CDDP and oral S-1in Kishiwada Tokushukai Hospital between January 2008 and February 2017. After surgical resection, the response of LNMs was studied to confirm the effect of NIPS on LNMs. RESULTS: After NIPS, 197 lymph nodes (LNs) (42.5%) were graded as G3, the progression in LNMs were significantly better than in the primary tumors. Until the last follow-up, 1-year overall survival rate was 82.6%, and the median survival period was 22.0 ± 3.7 months. In the group of patients who had achieved a more than 50% G3 grade of the response of LNMs, the median survival period is 38 months; in the less than 50% G3 grade group, it is 14 months, that is a significantly different result. Multivariate analyses showed that the factors PCI, Post-therapeutic N status and response of the LNMs were found to be as independent prognostic factors. CONCLUSION:
|
Authors | Y Hao, Y Liu, H Ishibashi, S Wakama, E Nishino, Y Yonemura |
Journal | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
(Eur J Surg Oncol)
Vol. 45
Issue 8
Pg. 1493-1497
(Aug 2019)
ISSN: 1532-2157 [Electronic] England |
PMID | 30948161
(Publication Type: Journal Article)
|
Copyright | Copyright © 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved. |
Topics |
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Chemotherapy, Adjuvant
- Cohort Studies
- Databases, Factual
- Disease-Free Survival
- Female
- Gastrectomy
(methods)
- Humans
- Infusions, Parenteral
- Japan
- Kaplan-Meier Estimate
- Lymph Node Excision
(methods)
- Lymph Nodes
(pathology, surgery)
- Lymphatic Metastasis
(pathology)
- Male
- Middle Aged
- Multivariate Analysis
- Neoadjuvant Therapy
(methods)
- Neoplasm Invasiveness
(pathology)
- Peritoneal Neoplasms
(mortality, secondary, therapy)
- Prognosis
- Proportional Hazards Models
- Retrospective Studies
- Stomach Neoplasms
(mortality, pathology, therapy)
- Survival Analysis
|